Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107th Yanjiangxi Road, Guangzhou, China.
Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.
J Transl Med. 2023 Jan 23;21(1):42. doi: 10.1186/s12967-023-03888-z.
BACKGROUND: Accurate pathological diagnosis of invasion depth and histologic grade is key for clinical management in patients with bladder cancer (BCa), but it is labour-intensive, experience-dependent and subject to interobserver variability. Here, we aimed to develop a pathological artificial intelligence diagnostic model (PAIDM) for BCa diagnosis. METHODS: A total of 854 whole slide images (WSIs) from 692 patients were included and divided into training and validation sets. The PAIDM was developed using the training set based on the deep learning algorithm ScanNet, and the performance was verified at the patch level in validation set 1 and at the WSI level in validation set 2. An independent validation cohort (validation set 3) was employed to compare the PAIDM and pathologists. Model performance was evaluated using the area under the curve (AUC), accuracy, sensitivity, specificity, positive predictive value and negative predictive value. RESULTS: The AUCs of the PAIDM were 0.878 (95% CI 0.875-0.881) at the patch level in validation set 1 and 0.870 (95% CI 0.805-0.923) at the WSI level in validation set 2. In comparing the PAIDM and pathologists, the PAIDM achieved an AUC of 0.847 (95% CI 0.779-0.905), which was non-inferior to the average diagnostic level of pathologists. There was high consistency between the model-predicted and manually annotated areas, improving the PAIDM's interpretability. CONCLUSIONS: We reported an artificial intelligence-based diagnostic model for BCa that performed well in identifying invasion depth and histologic grade. Importantly, the PAIDM performed admirably in patch-level recognition, with a promising application for transurethral resection specimens.
背景:膀胱癌(BCa)患者的临床管理的关键是准确的病理诊断浸润深度和组织学分级,但它是劳动密集型的,依赖经验,并受到观察者间的变异性。在这里,我们旨在开发一个用于膀胱癌诊断的病理人工智能诊断模型(PAIDM)。
方法:共纳入 692 例患者的 854 张全切片图像(WSI),并分为训练集和验证集。PAIDM 是基于深度学习算法 ScanNet 在训练集上开发的,并在验证集 1 的斑块水平和验证集 2 的 WSI 水平上进行验证。采用独立验证队列(验证集 3)比较 PAIDM 和病理学家。使用曲线下面积(AUC)、准确性、敏感性、特异性、阳性预测值和阴性预测值评估模型性能。
结果:PAIDM 在验证集 1 的斑块水平上的 AUC 为 0.878(95%CI 0.875-0.881),在验证集 2 的 WSI 水平上的 AUC 为 0.870(95%CI 0.805-0.923)。在比较 PAIDM 和病理学家时,PAIDM 达到了 0.847(95%CI 0.779-0.905)的 AUC,这与病理学家的平均诊断水平相当。模型预测和手动注释区域之间具有高度一致性,提高了 PAIDM 的可解释性。
结论:我们报告了一种基于人工智能的膀胱癌诊断模型,该模型在识别浸润深度和组织学分级方面表现良好。重要的是,PAIDM 在斑块级识别中表现出色,有望应用于经尿道切除标本。
Eur Radiol. 2020-12
Diagnostics (Basel). 2024-10-14
Bladder (San Franc). 2024-8-16
Animals (Basel). 2024-8-27
Investig Clin Urol. 2024-5
Med Image Anal. 2022-1
BMC Med Inform Decis Mak. 2020-7-17